Safety and Efficacy of an 11β-Hydroxysteroid Dehydrogenase Type-1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension

Update item information
Identifier 20180305_nanos_sciplatform1_02
Title Safety and Efficacy of an 11β-Hydroxysteroid Dehydrogenase Type-1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension
Creator Keira Markey, Ryan Ottridge, James Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, Tim Matthews, Anita Krishnan, Pushkar Shah, William Scotton, Susan Mollan, Alex Sinclair
Subject High intracranial pressure/headache, Pseudotumor Cerebri, Perimetry
Description Pharmacological therapy in IIH is limited. We investigated the safety, tolerability and efficacy of a novel drug, an 11β-hydroxysteroid dehydrogenase type-1 inhibitor (AZ4017).
Relation is Part of NANOS Annual Meeting 2018: Scientific Platform, Session I
Contributor Primary Keira Markey
Contributor Secondary Ryan Ottridge, James Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, Tim Matthews, Anita Krishnan, Pushkar Shah, William Scotton, Susan Mollan, Alex Sinclair
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2018-04
Format video/mp4
Source 2018 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s6hf1z4d
Setname ehsl_novel_nam
Date Created 2018-04-25
Date Modified 2018-04-25
ID 1316058
Reference URL https://collections.lib.utah.edu/ark:/87278/s6hf1z4d
Back to Search Results